As observed in clinical AD, studies using transgenic mice expressing human APP have shown that high levels of Aβ peptide are sufficient to induce epileptiform activity and seizures even in the early stages of the disease process, leading to depletion of hippocampal stem cells and impairments in spatial discrimination [7, 8]. Here, APP is linked to Alzheimer disease.